T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
46 hedge funds and large institutions have $19M invested in T2 Biosystems, Inc in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 7 closing their positions.
157% more capital invested
Capital invested by funds: $7.39M → $19M (+$11.6M)
154% more call options, than puts
Call options by funds: $553K | Put options by funds: $218K
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
18% more funds holding
Funds holding: 39 → 46 (+7)
18% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.17M |
| 2 |
BlackRock
New York
|
+$518K |
| 3 |
Squarepoint
New York
|
+$259K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$212K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$144K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$297K |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$202K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$76.4K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$72.2K |
| 5 |
IF
Ironwood Financial
Tucson,
Arizona
|
-$63.7K |
TTOO Hedge Fund Activity: Q2 2020 in Review
46 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2020, worth a combined $19M — up 157% from $7.39M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new TTOO positions and 7 closed out — a net gain of 8 holders — while 9 added to existing stakes and 11 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.17M. The largest seller was GSA Capital Partners, cutting an estimated $297K.
- 46 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2020, up from 39 in Q1 2020.
- Funds reported $19M of T2 Biosystems, Inc stock for Q2 2020, up 157% quarter-over-quarter.
- 15 funds opened new T2 Biosystems, Inc positions in Q2 2020 and 7 closed out, a net change of +8 holders.
- The largest T2 Biosystems, Inc buyer in Q2 2020 was Vanguard Group, an estimated $2.17M added.
- The largest T2 Biosystems, Inc seller in Q2 2020 was GSA Capital Partners, an estimated $297K sold.
Based on aggregated 13F filings for Q2 2020.